NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|158298653|ref|XP_318843|]
View 

AGAP009757-PA [Anopheles gambiae str. PEST]

Protein Classification

M2 family metallopeptidase( domain architecture ID 10157887)

M2 family metallopeptidase similar to angiotensin converting enzyme (ACE), a zinc-dependent dipeptidyl carboxypeptidase

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M2_ACE cd06461
Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin ...
287-860 0e+00

Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc-dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II, by removing two C-terminal amino acids. There are two forms of the enzyme in humans, the ubiquitous somatic ACE and the sperm-specific germinal ACE, both encoded by the same gene through transcription from alternative promoters. Somatic ACE has two tandem active sites with distinct catalytic properties, whereas germinal ACE, the function of which is largely unknown, has just a single active site. Recently, an ACE homolog, ACE2, has been identified in humans that differs from ACE; it preferentially removes carboxy-terminal hydrophobic or basic amino acids and appears to be important in cardiac function. ACE homologs (also known as members of the M2 gluzincin family) have been found in a wide variety of species, including those that neither have a cardiovascular system nor synthesize angiotensin. ACE is well-known as a key part of the renin-angiotensin system that regulates blood pressure and ACE inhibitors are important for the treatment of hypertension.


:

Pssm-ID: 341055  Cd Length: 563  Bit Score: 885.80  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 287 FLTEIDRKSSLECSLNVAAQWNFETNINDATQVEALAAQQRYNDFQRLLWDQMRRIDQTKIFDDKLYRQVRLMSIIGPSA 366
Cdd:cd06461    1 FLEEYNEEASKLYNRSAEAQWNYETNITDENLQALLEASLELSKFVKEAAENAKKFDWQDFLDPDLKRQLKLLSRLGVAA 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 367 LPPDQLDRYNRIVNDMLAIFNGATICAYEQPFECGLRLQPHLkdvseQSIMAKSRDWNELQYTWLEWRRKSGRNMRDLFE 446
Cdd:cd06461   81 LDEEDLEELNELLSEMEKIYSTAKVCPYDNPSCCCLLLEPDL-----TNILATSRDYDELLYAWKGWRDAVGKKMRPLYE 155
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 447 QLVDLTNDAGRVNNFTDAAAYWTFPYESRNFREEMEQVWREILPLYEMIHAYVRRKLREFYGPDKINKNAPLPDHILGDM 526
Cdd:cd06461  156 EYVELSNEAARLNGFADAGEYWRSSYEMDEFEEELERLWEQIKPLYEQLHAYVRRKLRKKYGDDVIPKDGPIPAHLLGNM 235
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 527 YGQSWQNILDIVIPYPGRSFLEVTPEMQKQGYNPLVMFQIAEEFFVSMNMSAMPPDFWASSIVTQPPDRPILCQPSSWDF 606
Cdd:cd06461  236 WAQSWSNIYDLVVPYPDKPSLDVTPELKKQNYTAKKMFKLAEEFFTSLGLPPLPKSFWEKSMFEKPPDREVVCHASAWDF 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 607 CTGKDYRVKMCTQVTHKDFITVHHELAHIQYFLNYRNNPKVFRDGANPGFHEAIGDAISLSVASPKHLQNLGLVQKSVDD 686
Cdd:cd06461  316 YNGDDFRIKMCTEVTMEDFLTVHHEMGHIQYYMAYKDQPVLFREGANPGFHEAIGDTIALSVSTPKHLKRLGLLDDNVDD 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 687 TAHDINFLFSLAMEKVVFLPFALALEAWRYDVFSKRVRKEQYNCHWWLLREEYGGVKPPVLRSELDFDPGAKYHVAANIP 766
Cdd:cd06461  396 EEADINFLLKQALDKIAFLPFGYLLDKWRWDVFSGEIPPDEYNEAWWELREKYQGIVPPVPRSEEDFDPGAKYHIPANTP 475
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 767 YIKYFFSNVLQFQIYRALCTASGQyvpqdpSKPLHKCDIYRQPAAGNILKKLMERGTSQPWQQVLQEVIGEGRLDGSALR 846
Cdd:cd06461  476 YIRYFLSTILQFQFHKALCKAAGH------TGPLHKCDIYGSKEAGKKLKKMLSLGSSKPWPDALEELTGERELDASPLL 549
                        570
                 ....*....|....
gi 158298653 847 EFFRPLEEWLRNEN 860
Cdd:cd06461  550 EYFQPLYDWLKEEN 563
 
Name Accession Description Interval E-value
M2_ACE cd06461
Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin ...
287-860 0e+00

Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc-dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II, by removing two C-terminal amino acids. There are two forms of the enzyme in humans, the ubiquitous somatic ACE and the sperm-specific germinal ACE, both encoded by the same gene through transcription from alternative promoters. Somatic ACE has two tandem active sites with distinct catalytic properties, whereas germinal ACE, the function of which is largely unknown, has just a single active site. Recently, an ACE homolog, ACE2, has been identified in humans that differs from ACE; it preferentially removes carboxy-terminal hydrophobic or basic amino acids and appears to be important in cardiac function. ACE homologs (also known as members of the M2 gluzincin family) have been found in a wide variety of species, including those that neither have a cardiovascular system nor synthesize angiotensin. ACE is well-known as a key part of the renin-angiotensin system that regulates blood pressure and ACE inhibitors are important for the treatment of hypertension.


Pssm-ID: 341055  Cd Length: 563  Bit Score: 885.80  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 287 FLTEIDRKSSLECSLNVAAQWNFETNINDATQVEALAAQQRYNDFQRLLWDQMRRIDQTKIFDDKLYRQVRLMSIIGPSA 366
Cdd:cd06461    1 FLEEYNEEASKLYNRSAEAQWNYETNITDENLQALLEASLELSKFVKEAAENAKKFDWQDFLDPDLKRQLKLLSRLGVAA 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 367 LPPDQLDRYNRIVNDMLAIFNGATICAYEQPFECGLRLQPHLkdvseQSIMAKSRDWNELQYTWLEWRRKSGRNMRDLFE 446
Cdd:cd06461   81 LDEEDLEELNELLSEMEKIYSTAKVCPYDNPSCCCLLLEPDL-----TNILATSRDYDELLYAWKGWRDAVGKKMRPLYE 155
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 447 QLVDLTNDAGRVNNFTDAAAYWTFPYESRNFREEMEQVWREILPLYEMIHAYVRRKLREFYGPDKINKNAPLPDHILGDM 526
Cdd:cd06461  156 EYVELSNEAARLNGFADAGEYWRSSYEMDEFEEELERLWEQIKPLYEQLHAYVRRKLRKKYGDDVIPKDGPIPAHLLGNM 235
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 527 YGQSWQNILDIVIPYPGRSFLEVTPEMQKQGYNPLVMFQIAEEFFVSMNMSAMPPDFWASSIVTQPPDRPILCQPSSWDF 606
Cdd:cd06461  236 WAQSWSNIYDLVVPYPDKPSLDVTPELKKQNYTAKKMFKLAEEFFTSLGLPPLPKSFWEKSMFEKPPDREVVCHASAWDF 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 607 CTGKDYRVKMCTQVTHKDFITVHHELAHIQYFLNYRNNPKVFRDGANPGFHEAIGDAISLSVASPKHLQNLGLVQKSVDD 686
Cdd:cd06461  316 YNGDDFRIKMCTEVTMEDFLTVHHEMGHIQYYMAYKDQPVLFREGANPGFHEAIGDTIALSVSTPKHLKRLGLLDDNVDD 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 687 TAHDINFLFSLAMEKVVFLPFALALEAWRYDVFSKRVRKEQYNCHWWLLREEYGGVKPPVLRSELDFDPGAKYHVAANIP 766
Cdd:cd06461  396 EEADINFLLKQALDKIAFLPFGYLLDKWRWDVFSGEIPPDEYNEAWWELREKYQGIVPPVPRSEEDFDPGAKYHIPANTP 475
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 767 YIKYFFSNVLQFQIYRALCTASGQyvpqdpSKPLHKCDIYRQPAAGNILKKLMERGTSQPWQQVLQEVIGEGRLDGSALR 846
Cdd:cd06461  476 YIRYFLSTILQFQFHKALCKAAGH------TGPLHKCDIYGSKEAGKKLKKMLSLGSSKPWPDALEELTGERELDASPLL 549
                        570
                 ....*....|....
gi 158298653 847 EFFRPLEEWLRNEN 860
Cdd:cd06461  550 EYFQPLYDWLKEEN 563
Peptidase_M2 pfam01401
Angiotensin-converting enzyme; Members of this family are dipeptidyl carboxydipeptidases ...
279-869 0e+00

Angiotensin-converting enzyme; Members of this family are dipeptidyl carboxydipeptidases (cleave carboxyl dipeptides) and most notably convert angiotensin I to angiotensin II. Many members of this family contain a tandem duplication of the 600 amino acid peptidase domain, both of these are catalytically active. Most members are secreted membrane bound ectoenzymes.


Pssm-ID: 460196  Cd Length: 581  Bit Score: 804.11  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  279 AETEKLRAFLTEIDRKSSLECSLNVAAQWNFETNINDATQVEALAAQQRYNDFQRLLWDQMRRIDQTKIFDDKLYRQVRL 358
Cdd:pfam01401   2 TDEAEAREFLEEYNREAEKVLNESTEASWNYNTNITDENAQKMLEASLELAAFTKETAQEAKQFDWSNFQDPDLKRQFKK 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  359 MSIIGPSALPPDQLDRYNRIVNDMLAIFNGATICAYEQPFECgLRLQPHLkdvseQSIMAKSRDWNELQYTWLEWRRKSG 438
Cdd:pfam01401  82 LSVLGTAALPEDKLEELNTILSEMESIYSKAKVCLYDDPGPC-LSLEPDL-----TEIMATSRDYDELLWAWEGWRDAVG 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  439 RNMRDLFEQLVDLTNDAGRVNNFTDAAAYWTFPYESRNFREEMEQVWREILPLYEMIHAYVRRKLREFYGPDKINKNAPL 518
Cdd:pfam01401 156 KPLRPLYERYVELSNEAAKLNGYADTGAYWRSWYESDTFEEDLERLFQQLKPLYLQLHAYVRRKLREKYGPDVISLTGPI 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  519 PDHILGDMYGQSWQNILDIVIPYPGRSFLEVTPEMQKQGYNPLVMFQIAEEFFVSMNMSAMPPDFWASSIVTQPPD-RPI 597
Cdd:pfam01401 236 PAHLLGNMWAQSWSNIYDLVVPFPDKPNIDVTDAMVAQGYTAKKMFEEAEEFFTSLGLLPMPPEFWDKSMLEKPTDgREV 315
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  598 LCQPSSWDFCTGKDYRVKMCTQVTHKDFITVHHELAHIQYFLNYRNNPKVFRDGANPGFHEAIGDAISLSVASPKHLQNL 677
Cdd:pfam01401 316 VCHASAWDFYNGKDFRIKMCTEVTMEDFFTVHHEMGHIQYYLQYKDQPVLFREGANPGFHEAVGDVLALSVSTPKHLKSI 395
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  678 GLVQKSVDDTAHDINFLFSLAMEKVVFLPFALALEAWRYDVFSKRVRKEQYNCHWWLLREEYGGVKPPVLRSELDFDPGA 757
Cdd:pfam01401 396 GLLDDVVEDEESDINFLLKQALDKIAFLPFGYLIDKWRWGVFSGEIPPEDYNKRWWELRLKYQGICPPVPRTESDFDPGA 475
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  758 KYHVAANIPYIKYFFSNVLQFQIYRALCTASGQYVpqdpskPLHKCDIYRQPAAGNILKKLMERGTSQPWQQVLQEVIGE 837
Cdd:pfam01401 476 KYHVPANVPYIRYFVSFILQFQFHKALCQAAGHTG------PLHKCDIYGSKEAGAKLKEMLKLGSSKPWPEALEAITGQ 549
                         570       580       590
                  ....*....|....*....|....*....|..
gi 158298653  838 GRLDGSALREFFRPLEEWLRNENLRNNEYVGW 869
Cdd:pfam01401 550 RKMDASALLEYFEPLIDWLKEQNERNGEIVGW 581
 
Name Accession Description Interval E-value
M2_ACE cd06461
Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin ...
287-860 0e+00

Peptidase family M2, angiotensin converting enzyme (ACE); Peptidase family M2 angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc-dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II, by removing two C-terminal amino acids. There are two forms of the enzyme in humans, the ubiquitous somatic ACE and the sperm-specific germinal ACE, both encoded by the same gene through transcription from alternative promoters. Somatic ACE has two tandem active sites with distinct catalytic properties, whereas germinal ACE, the function of which is largely unknown, has just a single active site. Recently, an ACE homolog, ACE2, has been identified in humans that differs from ACE; it preferentially removes carboxy-terminal hydrophobic or basic amino acids and appears to be important in cardiac function. ACE homologs (also known as members of the M2 gluzincin family) have been found in a wide variety of species, including those that neither have a cardiovascular system nor synthesize angiotensin. ACE is well-known as a key part of the renin-angiotensin system that regulates blood pressure and ACE inhibitors are important for the treatment of hypertension.


Pssm-ID: 341055  Cd Length: 563  Bit Score: 885.80  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 287 FLTEIDRKSSLECSLNVAAQWNFETNINDATQVEALAAQQRYNDFQRLLWDQMRRIDQTKIFDDKLYRQVRLMSIIGPSA 366
Cdd:cd06461    1 FLEEYNEEASKLYNRSAEAQWNYETNITDENLQALLEASLELSKFVKEAAENAKKFDWQDFLDPDLKRQLKLLSRLGVAA 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 367 LPPDQLDRYNRIVNDMLAIFNGATICAYEQPFECGLRLQPHLkdvseQSIMAKSRDWNELQYTWLEWRRKSGRNMRDLFE 446
Cdd:cd06461   81 LDEEDLEELNELLSEMEKIYSTAKVCPYDNPSCCCLLLEPDL-----TNILATSRDYDELLYAWKGWRDAVGKKMRPLYE 155
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 447 QLVDLTNDAGRVNNFTDAAAYWTFPYESRNFREEMEQVWREILPLYEMIHAYVRRKLREFYGPDKINKNAPLPDHILGDM 526
Cdd:cd06461  156 EYVELSNEAARLNGFADAGEYWRSSYEMDEFEEELERLWEQIKPLYEQLHAYVRRKLRKKYGDDVIPKDGPIPAHLLGNM 235
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 527 YGQSWQNILDIVIPYPGRSFLEVTPEMQKQGYNPLVMFQIAEEFFVSMNMSAMPPDFWASSIVTQPPDRPILCQPSSWDF 606
Cdd:cd06461  236 WAQSWSNIYDLVVPYPDKPSLDVTPELKKQNYTAKKMFKLAEEFFTSLGLPPLPKSFWEKSMFEKPPDREVVCHASAWDF 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 607 CTGKDYRVKMCTQVTHKDFITVHHELAHIQYFLNYRNNPKVFRDGANPGFHEAIGDAISLSVASPKHLQNLGLVQKSVDD 686
Cdd:cd06461  316 YNGDDFRIKMCTEVTMEDFLTVHHEMGHIQYYMAYKDQPVLFREGANPGFHEAIGDTIALSVSTPKHLKRLGLLDDNVDD 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 687 TAHDINFLFSLAMEKVVFLPFALALEAWRYDVFSKRVRKEQYNCHWWLLREEYGGVKPPVLRSELDFDPGAKYHVAANIP 766
Cdd:cd06461  396 EEADINFLLKQALDKIAFLPFGYLLDKWRWDVFSGEIPPDEYNEAWWELREKYQGIVPPVPRSEEDFDPGAKYHIPANTP 475
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 767 YIKYFFSNVLQFQIYRALCTASGQyvpqdpSKPLHKCDIYRQPAAGNILKKLMERGTSQPWQQVLQEVIGEGRLDGSALR 846
Cdd:cd06461  476 YIRYFLSTILQFQFHKALCKAAGH------TGPLHKCDIYGSKEAGKKLKKMLSLGSSKPWPDALEELTGERELDASPLL 549
                        570
                 ....*....|....
gi 158298653 847 EFFRPLEEWLRNEN 860
Cdd:cd06461  550 EYFQPLYDWLKEEN 563
Peptidase_M2 pfam01401
Angiotensin-converting enzyme; Members of this family are dipeptidyl carboxydipeptidases ...
279-869 0e+00

Angiotensin-converting enzyme; Members of this family are dipeptidyl carboxydipeptidases (cleave carboxyl dipeptides) and most notably convert angiotensin I to angiotensin II. Many members of this family contain a tandem duplication of the 600 amino acid peptidase domain, both of these are catalytically active. Most members are secreted membrane bound ectoenzymes.


Pssm-ID: 460196  Cd Length: 581  Bit Score: 804.11  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  279 AETEKLRAFLTEIDRKSSLECSLNVAAQWNFETNINDATQVEALAAQQRYNDFQRLLWDQMRRIDQTKIFDDKLYRQVRL 358
Cdd:pfam01401   2 TDEAEAREFLEEYNREAEKVLNESTEASWNYNTNITDENAQKMLEASLELAAFTKETAQEAKQFDWSNFQDPDLKRQFKK 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  359 MSIIGPSALPPDQLDRYNRIVNDMLAIFNGATICAYEQPFECgLRLQPHLkdvseQSIMAKSRDWNELQYTWLEWRRKSG 438
Cdd:pfam01401  82 LSVLGTAALPEDKLEELNTILSEMESIYSKAKVCLYDDPGPC-LSLEPDL-----TEIMATSRDYDELLWAWEGWRDAVG 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  439 RNMRDLFEQLVDLTNDAGRVNNFTDAAAYWTFPYESRNFREEMEQVWREILPLYEMIHAYVRRKLREFYGPDKINKNAPL 518
Cdd:pfam01401 156 KPLRPLYERYVELSNEAAKLNGYADTGAYWRSWYESDTFEEDLERLFQQLKPLYLQLHAYVRRKLREKYGPDVISLTGPI 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  519 PDHILGDMYGQSWQNILDIVIPYPGRSFLEVTPEMQKQGYNPLVMFQIAEEFFVSMNMSAMPPDFWASSIVTQPPD-RPI 597
Cdd:pfam01401 236 PAHLLGNMWAQSWSNIYDLVVPFPDKPNIDVTDAMVAQGYTAKKMFEEAEEFFTSLGLLPMPPEFWDKSMLEKPTDgREV 315
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  598 LCQPSSWDFCTGKDYRVKMCTQVTHKDFITVHHELAHIQYFLNYRNNPKVFRDGANPGFHEAIGDAISLSVASPKHLQNL 677
Cdd:pfam01401 316 VCHASAWDFYNGKDFRIKMCTEVTMEDFFTVHHEMGHIQYYLQYKDQPVLFREGANPGFHEAVGDVLALSVSTPKHLKSI 395
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  678 GLVQKSVDDTAHDINFLFSLAMEKVVFLPFALALEAWRYDVFSKRVRKEQYNCHWWLLREEYGGVKPPVLRSELDFDPGA 757
Cdd:pfam01401 396 GLLDDVVEDEESDINFLLKQALDKIAFLPFGYLIDKWRWGVFSGEIPPEDYNKRWWELRLKYQGICPPVPRTESDFDPGA 475
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653  758 KYHVAANIPYIKYFFSNVLQFQIYRALCTASGQYVpqdpskPLHKCDIYRQPAAGNILKKLMERGTSQPWQQVLQEVIGE 837
Cdd:pfam01401 476 KYHVPANVPYIRYFVSFILQFQFHKALCQAAGHTG------PLHKCDIYGSKEAGAKLKEMLKLGSSKPWPEALEAITGQ 549
                         570       580       590
                  ....*....|....*....|....*....|..
gi 158298653  838 GRLDGSALREFFRPLEEWLRNENLRNNEYVGW 869
Cdd:pfam01401 550 RKMDASALLEYFEPLIDWLKEQNERNGEIVGW 581
M3_like cd06258
M3-like Peptidases, zincin metallopeptidases, include M2_ACE, M3A, M3B_PepF, and M32 families; ...
440-846 1.48e-69

M3-like Peptidases, zincin metallopeptidases, include M2_ACE, M3A, M3B_PepF, and M32 families; The peptidase M3-like family, also called neurolysin-like family, is part of the "zincin" metallopeptidases, and includes the M2, M3 and M32 families of metallopeptidases. The M2 angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc-dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. The M3 family is subdivided into two subfamilies: the widespread M3A, which comprises a number of high-molecular mass endo- and exopeptidases from bacteria, archaea, protozoa, fungi, plants and animals, and the small M3B, whose members are enzymes primarily from bacteria. Well-known mammalian/eukaryotic M3A endopeptidases are the thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (alias endopeptidase 3.4.24.16), and the mitochondrial intermediate peptidase. The first two are intracellular oligopeptidases, which act only on relatively short substrates of less than 20 amino acid residues, while the latter cleaves N-terminal octapeptides from proteins during their import into the mitochondria. The M3A subfamily also contains several bacterial endopeptidases, called oligopeptidases A, as well as a large number of bacterial carboxypeptidases, called dipeptidyl peptidases (Dcp; Dcp II; peptidyl dipeptidase; EC 3.4.15.5). M3B subfamily consists of oligopeptidase F (PepF) which hydrolyzes peptides containing 7-17 amino acid residues with fairly broad specificity. Peptidases in the M3 family contain the HEXXH motif that forms part of the active site in conjunction with a C-terminally-located Glutamic acid (Glu) residue. A single zinc ion is ligated by the side-chains of the two Histidine (His) residues, and the more C-terminal Glu. Most of the peptidases are synthesized without signal peptides or propeptides, and function intracellularly. There are similarities to the thermostable carboxypeptidases from Pyrococcus furiosus carboxypeptidase (PfuCP), and Thermus aquaticus (TaqCP), belonging to peptidase family M32. Little is known about function of this family, including carboxypeptidases Taq and Pfu.


Pssm-ID: 341049 [Multi-domain]  Cd Length: 473  Bit Score: 238.87  E-value: 1.48e-69
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 440 NMRDLFEQLVDLTNDAGRVNNFTDAAAYWTFPYESRNFREE----MEQVWREILPLYEMIHAYVRRKLREFYGPDKINKn 515
Cdd:cd06258  103 ELRPLLEKLVELRNQAARLLGYEDPYDALLDLYEAGYSTEVveqdFEELKQAIPLLYKELHAIQRPKLHRDYGFYYIPK- 181
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 516 aplpdhilgdmygqswqnildivipypgrsfLEVTPEMQKQGYNPLVMFQIAEEFFVSMNMSAMPPDFWASSIVTQPPDR 595
Cdd:cd06258  182 -------------------------------FDVTSAMLKQKFDAEWMFEGALWFLQELGLEPGPLLTWERLDLYAPLGK 230
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 596 piLCQPSSWDFcTGKDYRVKMCTQVTHKDFITVHHELAHIQYFLNYRNNPKVFRDGANPGFHEAIGDAISLSVASPKHLQ 675
Cdd:cd06258  231 --VCHAFATDF-GRKDVRITTNYTVTRDDILTTHHEFGHALYELQYRTRFAFLGNGASLGFHESQSQFLENSVGTFKHLY 307
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 676 NLGLVQKSVDDTAHDINFLFSLAMEKVVFLPFALALEAWRYDVFSKRVRKEQYNCHWWLLREEYGGVKPPVLRSELDFDP 755
Cdd:cd06258  308 SKHLLSGPQMDDESEEKFLLARLLDKVTFLPHIILVDKWEWAVFSGEIPKKPDLPSWWNLLYKEYLGVPPVPRDETYTDG 387
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 158298653 756 GAKYHVAA--NIPYIKYFFSNVLQFQIYRALCTASGQYvpqdpskplHKCDIYRQPAAGNILKKLMERGTSQPWQQVLQE 833
Cdd:cd06258  388 WAQFHHWAgyDGYYIRYALGQVYAFQFYEKLCEDAGHE---------GKCDIGNFDEAGQKLREILRLGGSRPPTELLKN 458
                        410
                 ....*....|...
gi 158298653 834 VIGEGRLDGSALR 846
Cdd:cd06258  459 ATGKEPNIASFLL 471
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH